Pacs Group Inc (PACS) Stock Analysis
Verdict: HOLD
Aggressive M&A-driven growth and Q1 'blowout' earnings justify a sector premium, but extreme debt and insider selling warrant caution.
Investment score: 64/100
Analysis as of
Is Pacs Group Inc stock worth reviewing? The TradeMates thesis
PACS is currently priced for perfection after a massive post-earnings rally. While operational growth is undeniable, the model suggests waiting for a pullback given the 2.99 Debt/Equity ratio and recent insider selling.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 60/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 55/100 (weight 15%)
Pacs Group Inc opportunities and risks
What speaks for PACS
- Aggressive Revenue Expansion
What speaks against PACS
- Extreme Leverage Profile (6.6x Net Debt/EBITDA)
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PACS | 26.4x | 1.2x | 21.8x | 23.0% | 4.5% | 3.4% |
| HCA | 14.3x | 1.2x | 9.2x | 34.9% | 8.9% | 8.3% |
| THC | 10.0x | 0.8x | 6.2x | 42.8% | 7.9% | 19.8% |
| EHC | 17.6x | 1.8x | 9.2x | 58.8% | 10.0% | 4.3% |
| ENSG | 28.0x | 2.0x | 20.2x | 13.9% | 6.9% | 3.9% |
| UHS | 6.8x | 0.6x | 5.6x | 71.3% | 8.6% | 8.4% |
| Peer median | 14.3x | 1.2x | 9.2x | 42.8% | 8.6% | 8.3% |
Frequently asked questions about Pacs Group Inc (PACS)
Is PACS stock a good investment?
The TradeMates model rates Pacs Group Inc as HOLD with an investment score of 64/100. PACS is currently priced for perfection after a massive post-earnings rally. While operational growth is undeniable, the model suggests waiting for a pullback given the 2.99 Debt/Equity ratio and recent insider selling. This is algorithmic model output, not personal investment advice.
Is PACS stock a buy?
The TradeMates model verdict for PACS is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.